ADDvise receives allocation decision worth approximately 2.7 MSEK - Regulatory information
ADDvise Group AB's (publ) subsidiary Sonar Oy has received an allocation decision from Oulaskangas Hospital worth approximately 2.7 MSEK regarding X-ray equipment. Delivery of the equipment is planned to take place during Q3 2019.- We are glad that we through our latest acquisition are strengthening ADDvise’s position on the Finnish market. ADDvise is developing the future healthcare and we are very proud over that says Rikard Akhtarzand, CEO of ADDvise Group.The appeal time for the allocation decision expires April 17th 2019. For further information, please contact:Rikard